For several years, the role of immune system in the pathophysiology of psychosis has been well-recognized, showing differences from the onset to chronic phases. Our study aims to implement a biomarker-based classification model suitable for the clinical management of psychotic patients. A machine learning algorithm was used to classify a cohort of 362 subjects, including 160 first-episode psychosis patients (FEP), 70 patients affected by chronic psychiatric disorders (schizophrenia, bipolar disorder, and major depressive disorder) with psychosis (CRO) and 132 health controls (HC), based on mRNA transcript levels of 56 immune genes. Models distinguished between FEP, CRO, and HC and between the subgroup of drug-free FEP and HC with a mean accuracy of 80.8% and 90.4%, respectively. Interestingly, by using the feature importance method, we identified some immune gene transcripts that contribute most to the classification accuracy, possibly giving new insights on the immunopathogenesis of psychosis. Therefore, our results suggest that our classification model has a high translational potential, which may pave the way for a personalized management of psychosis.

Classification of Psychoses Based on Immunological Features: A Machine Learning Study in a Large Cohort of First-Episode and Chronic Patients / P. Enrico, G. Delvecchio, N. Turtulici, A. Pigoni, F.M. Villa, C. Perlini, M.G. Rossetti, M. Bellani, A. Lasalvia, C. Bonetto, P. Scocco, A. D'Agostino, S. Torresani, M. Imbesi, F. Bellini, A. Veronese, L. Bocchio-Chiavetto, M. Gennarelli, M. Balestrieri, G.I. Colombo, A. Finardi, M. Ruggeri, R. Furlan, P. Brambilla. - In: SCHIZOPHRENIA BULLETIN. - ISSN 0586-7614. - (2021). [Epub ahead of print] [10.1093/schbul/sbaa190]

Classification of Psychoses Based on Immunological Features: A Machine Learning Study in a Large Cohort of First-Episode and Chronic Patients

P. Enrico;G. Delvecchio;N. Turtulici;A. Pigoni;A. D'Agostino;F. Bellini;A. Finardi;R. Furlan;P. Brambilla
2021

Abstract

For several years, the role of immune system in the pathophysiology of psychosis has been well-recognized, showing differences from the onset to chronic phases. Our study aims to implement a biomarker-based classification model suitable for the clinical management of psychotic patients. A machine learning algorithm was used to classify a cohort of 362 subjects, including 160 first-episode psychosis patients (FEP), 70 patients affected by chronic psychiatric disorders (schizophrenia, bipolar disorder, and major depressive disorder) with psychosis (CRO) and 132 health controls (HC), based on mRNA transcript levels of 56 immune genes. Models distinguished between FEP, CRO, and HC and between the subgroup of drug-free FEP and HC with a mean accuracy of 80.8% and 90.4%, respectively. Interestingly, by using the feature importance method, we identified some immune gene transcripts that contribute most to the classification accuracy, possibly giving new insights on the immunopathogenesis of psychosis. Therefore, our results suggest that our classification model has a high translational potential, which may pave the way for a personalized management of psychosis.
psychosis; immunity; machine learning; transcriptomics; immune biomarkers; personalized medicine
Settore MED/25 - Psichiatria
9-feb-2021
Article (author)
File in questo prodotto:
File Dimensione Formato  
sbaa190.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 576.13 kB
Formato Adobe PDF
576.13 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/813921
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 6
social impact